Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mesenchymal stem cell (MSC)-mediated delivery is a therapeutic approach that utilizes MSCs as vehicles for transporting therapeutic agents to specific target tissues or disease sites. MSCs possess inherent homing ability to sites of injury, inflammation, or tumors. They can deliver drugs, nanoparticles, genes, or proteins through various mechanisms, including paracrine secretion, direct transfer, and controlled drug release. This approach offers advantages such as biocompatibility, targeted delivery, and reduced off-target effects. Ongoing research focuses on improving homing efficiency, cargo loading techniques, and overall therapeutic efficacy.
MSCs act as carriers to deliver therapeutic agents to target tissues through homing, paracrine secretion (e.g., EVs, cytokines), direct transfer via gap junctions/tunneling nanotubes, or controlled drug release.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mesenchymal Stem Cell-Mediated Delivery (MSC-Mediated Delivery).